These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 3886191)

  • 41. Electrophysiologic effects of amrinone.
    Goldstein RA; Gray EL; Dougherty AH; Naccarelli GV
    Am J Cardiol; 1985 Jul; 56(3):25B-28B. PubMed ID: 4025155
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Effect of phosphodiesterase inhibitors on survival of patients with chronic congestive heart failure.
    Packer M
    Am J Cardiol; 1989 Jan; 63(2):41A-45A. PubMed ID: 2642629
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Effects of intracoronary and intravenous amrinone infusions in patients with cardiac failure and patients with near normal cardiac function.
    Wilmshurst PT; Thompson DS; Juul SM; Dittrich HC; Dawson JR; Walker JM; Jenkins BS; Coltart DJ; Webb-Peploe MM
    Br Heart J; 1985 May; 53(5):493-506. PubMed ID: 3994862
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A comparison of oral milrinone, digoxin, and their combination in the treatment of patients with chronic heart failure.
    DiBianco R; Shabetai R; Kostuk W; Moran J; Schlant RC; Wright R
    N Engl J Med; 1989 Mar; 320(11):677-83. PubMed ID: 2646536
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Effects of increasing maintenance dose of digoxin on left ventricular function and neurohormones in patients with chronic heart failure treated with diuretics and angiotensin-converting enzyme inhibitors.
    Gheorghiade M; Hall VB; Jacobsen G; Alam M; Rosman H; Goldstein S
    Circulation; 1995 Oct; 92(7):1801-7. PubMed ID: 7671364
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Effects of amrinone on myocardial energy metabolism and hemodynamics in patients with severe congestive heart failure due to coronary artery disease.
    Benotti JR; Grossman W; Braunwald E; Carabello BA
    Circulation; 1980 Jul; 62(1):28-34. PubMed ID: 7379283
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Haemodynamic dose-response effects of intravenous amrinone in left ventricular failure complicating acute myocardial infarction.
    Verma SP; Silke B; Reynolds GW; Hafizullah M; Jackson NC; Taylor SH
    J Cardiovasc Pharmacol; 1985; 7(6):1101-6. PubMed ID: 2418295
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Captopril in mild heart failure: preliminary observations of a long-term, double-blind, placebo-controlled multicentre trial.
    Magnani B; Magelli C
    Postgrad Med J; 1986; 62 Suppl 1():153-8. PubMed ID: 3534852
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Beneficial effects of pimobendan on exercise tolerance and quality of life in patients with heart failure. Results of a multicenter trial. The Pimobendan Multicenter Research Group.
    Kubo SH; Gollub S; Bourge R; Rahko P; Cobb F; Jessup M; Brozena S; Brodsky M; Kirlin P; Shanes J
    Circulation; 1992 Mar; 85(3):942-9. PubMed ID: 1537130
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The beneficial effect of amrinone on acute drug-induced heart failure in the anaesthetised dog.
    Alousi AA; Canter JM; Fort DJ
    Cardiovasc Res; 1985 Aug; 19(8):483-94. PubMed ID: 4042115
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Amrinone. A preliminary review of its pharmacological properties and therapeutic use.
    Ward A; Brogden RN; Heel RC; Speight TM; Avery GS
    Drugs; 1983 Dec; 26(6):468-502. PubMed ID: 6360634
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Randomized study assessing the effect of digoxin withdrawal in patients with mild to moderate chronic congestive heart failure: results of the PROVED trial. PROVED Investigative Group.
    Uretsky BF; Young JB; Shahidi FE; Yellen LG; Harrison MC; Jolly MK
    J Am Coll Cardiol; 1993 Oct; 22(4):955-62. PubMed ID: 8409069
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Amrinone: a promising new cardiotonic agent in the treatment of chronic cardiac failure.
    Likoff MJ; Weber KT; Andrews V; Janicki JS
    Herz; 1983 Aug; 8(4):199-205. PubMed ID: 6413341
    [No Abstract]   [Full Text] [Related]  

  • 54. Amrinone therapy in congestive cardiomyopathy.
    Reader C; Peyregne EA; Suárez LD
    Am Heart J; 1983 Jun; 105(6):1045. PubMed ID: 6858829
    [No Abstract]   [Full Text] [Related]  

  • 55. Milrinone, a new agent for the treatment of congestive heart failure.
    Hasegawa GR
    Clin Pharm; 1986 Mar; 5(3):201-5. PubMed ID: 3514085
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Exercise responses before and after long-term treatment with oral milrinone in patients with severe heart failure.
    Ribeiro JP; White HD; Arnold JM; Hartley LH; Colucci WS
    Am J Med; 1986 Nov; 81(5):759-64. PubMed ID: 3535490
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Influence of digitalis on left ventricular functional response to exercise in congestive heart failure.
    Morisco C; Cuocolo A; Romano M; Nappi A; Iaccarino G; Volpe M; Salvatore M; Trimarco B
    Am J Cardiol; 1996 Mar; 77(7):480-5. PubMed ID: 8629588
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A placebo-controlled trial of captopril in refractory chronic congestive heart failure. Captopril Multicenter Research Group.
    J Am Coll Cardiol; 1983 Oct; 2(4):755-63. PubMed ID: 6350401
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Effects of amrinone on myocardial energetics in severe congestive heart failure.
    Baim DS
    Am J Cardiol; 1985 Jul; 56(3):16B-18B. PubMed ID: 3161318
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Echocardiographic evaluation of cardiovascular effects of amrinone.
    Modena MG; Benassi A; Mattioli G
    Clin Cardiol; 1984 Nov; 7(11):593-8. PubMed ID: 6499289
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.